These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5075981)

  • 61. [Persistence of Koch bacilli in cerebrospinal fluid in tuberculous meningitis during phase of improvement or after clinical cure].
    BERMEJILLO MARTINEZ M
    Medicina (Madr); 1953 May; 21(1:5):299-300. PubMed ID: 13110523
    [No Abstract]   [Full Text] [Related]  

  • 62. [Content of bisulfite-binding substances in the cerebrospinal fluid in tuberculous meningitis treated with streptomycin].
    IUZEFOVICH EK; CHERNIUK VP
    Probl Tuberk; 1954; 1():47-51. PubMed ID: 13155483
    [No Abstract]   [Full Text] [Related]  

  • 63. Cerebrospinal fluid immunoglobulins G, A & M in pyogenic and tuberculous meningitis.
    Pole SL; Khare PM; Kelkar SS
    Indian J Pathol Microbiol; 1983 Jul; 26(3):193-9. PubMed ID: 6421730
    [No Abstract]   [Full Text] [Related]  

  • 64. [Determination of p-aminosalicylic acid hydrazide in cerebrospinal fluid in normal subjects and in tuberculous meningitis].
    ORESTANO G; GHIONE M; CHIARLO B
    Arch Ital Sci Farmacol; 1954 Jul; 4(3):369-73. PubMed ID: 13229623
    [No Abstract]   [Full Text] [Related]  

  • 65. Characteristics of cerebrospinal fluid in tuberculous meningitis.
    Jeren T; Beus I
    Acta Cytol; 1982; 26(5):678-80. PubMed ID: 6959457
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The composition of the cerebrospinal fluid in children with tuberculous meningitis with different patterns of the mycobacterial population].
    Gadzhiev GS; Alieva LP
    Probl Tuberk; 1996; (4):44-5. PubMed ID: 9026805
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Potentialities of laboratory diagnosis in tuberculous meningitis].
    Kulikovskaia NV; Vaneeva TV; Moroz I; Nosova EIu; Lazareva OL; Lovacheva OV; Litvinov VI
    Probl Tuberk Bolezn Legk; 2005; (8):39-42. PubMed ID: 16209019
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Passage of rifampicin through the hemato-liquor barrier].
    Rossolini A; Mattei C; Bianchini AM
    Minerva Pediatr; 1972 Aug; 24(28):1170-4. PubMed ID: 4639063
    [No Abstract]   [Full Text] [Related]  

  • 69. Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis.
    Ellard GA; Humphries MJ; Gabriel M; Teoh R
    Br Med J (Clin Res Ed); 1987 Jan; 294(6567):284-5. PubMed ID: 3101843
    [No Abstract]   [Full Text] [Related]  

  • 70. Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials.
    Svensson EM; Dian S; Te Brake L; Ganiem AR; Yunivita V; van Laarhoven A; Van Crevel R; Ruslami R; Aarnoutse RE
    Clin Infect Dis; 2020 Nov; 71(8):1817-1823. PubMed ID: 31665299
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial.
    Wasserman S; Davis A; Stek C; Chirehwa M; Botha S; Daroowala R; Bremer M; Maxebengula M; Koekemoer S; Goliath R; Jackson A; Crede T; Naude J; Szymanski P; Vallie Y; Moosa MS; Wiesner L; Black J; Meintjes G; Maartens G; Wilkinson RJ
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0014021. PubMed ID: 33972248
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis.
    Abdelgawad N; Tshavhungwe MP; Rohlwink U; McIlleron H; Abdelwahab MT; Wiesner L; Castel S; Steele C; Enslin JN; Thango NS; Denti P; Figaji A
    Antimicrob Agents Chemother; 2023 Mar; 67(3):e0147422. PubMed ID: 36815838
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Jaundice appearing in the course of rifampicin treatment in a child with a grave form of tuberculosis].
    Tonceanu S; Bazacliu E; Carp G
    Ftiziologia; 1972; 21(1):93-8. PubMed ID: 4664528
    [No Abstract]   [Full Text] [Related]  

  • 74. [Letter: Rifampicin: blood and cerebrospinal fluid levels in children].
    Rautlin de la Roy Y DE; Hoppeler A; Creusot G; Brault AM
    Nouv Presse Med; 1973 Sep; 2(33):2200-1. PubMed ID: 4748629
    [No Abstract]   [Full Text] [Related]  

  • 75. [Rifampicin levels in the serum and cerebrospinal fluid in children].
    de Rautlin de la Roy Y; Hoppeler A; Creusot G; Brault AM
    Arch Fr Pediatr; 1974 May; 31(5):477-88. PubMed ID: 4441230
    [No Abstract]   [Full Text] [Related]  

  • 76. High-dose rifampin improves bactericidal activity without increased intracerebral inflammation in animal models of tuberculous meningitis.
    Ruiz-Bedoya CA; Mota F; Tucker EW; Mahmud FJ; Reyes-Mantilla MI; Erice C; Bahr M; Flavahan K; de Jesus P; Kim J; Foss CA; Peloquin CA; Hammoud DA; Ordonez AA; Pardo CA; Jain SK
    J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35085105
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Rifampicin-induced hepatitis in childhood].
    Bedir O; Yalcin E; Eskinasis N
    Monatsschr Kinderheilkd (1902); 1978 May; 126(5):337-9. PubMed ID: 651930
    [No Abstract]   [Full Text] [Related]  

  • 78. More adverse reactions to rifampicin.
    Gutman L
    J Antimicrob Chemother; 1978 May; 4(3):283. PubMed ID: 670121
    [No Abstract]   [Full Text] [Related]  

  • 79. Intrathecal hydrocortisone in the treatment of tuberculous meningitis (preliminary report).
    Harsoyo N; Trastotenojo MS; Soejono ; Abubakar D; Warman I
    Paediatr Indones; 1976; 16(9-10):355-60. PubMed ID: 1037020
    [No Abstract]   [Full Text] [Related]  

  • 80. Author Response: Atul Krishnan Ramesh, New York:
    Ramesh AK
    Neurology; 2015 May; 84(21):2201. PubMed ID: 26213723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.